Cargando…

Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series

BACKGROUND: To predict the effectiveness of topical glaucoma medications based on initial uniocular and binocular treatment. To test a traditional hypothesis that effectiveness following a uniocular trial is associated with the change in IOP in the initially treated eye minus the change in the initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Leffler, Christopher T, Amini, Lina
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093925/
https://www.ncbi.nlm.nih.gov/pubmed/17916260
http://dx.doi.org/10.1186/1471-2415-7-17
_version_ 1782138202564329472
author Leffler, Christopher T
Amini, Lina
author_facet Leffler, Christopher T
Amini, Lina
author_sort Leffler, Christopher T
collection PubMed
description BACKGROUND: To predict the effectiveness of topical glaucoma medications based on initial uniocular and binocular treatment. To test a traditional hypothesis that effectiveness following a uniocular trial is associated with the change in IOP in the initially treated eye minus the change in the initially untreated eye. To determine whether uniocular or binocular treatment trials are superior. METHODS: Based on a review of medical records, we identified 168 instances in 154 patients with bilateral primary open angle glaucoma of initial uniocular use of a topical glaucoma medication with well-documented intraocular pressure (IOP) readings at baseline (IOP(A)), during the trial (IOP(B)), and at follow-up (IOP(C)). Abstracted data included demographic data, IOP, and medication use. Predictors of the IOP following the trial (IOP(C)) in each eye were identified by multivariable linear regression. In 70 cases, the predictive ability of initial uniocular and binocular treatment could be directly compared. RESULTS: In a multivariable analysis, the follow-up pressure in the initially treated eye (IOP(1C)) was directly correlated with treated eye IOP during initial uniocular use (IOP(1B), p < 0.001). In a multivariable analysis, the follow-up pressure in the initially untreated eye (IOP(2C)) was directly correlated with its baseline IOP(2A )(p < 0.001), and also tended to be associated with treated IOP(1B )(p = 0.07). The multivariable regression coefficient (b) for the IOP change in the initially untreated eye was generally not close to the value of -1 expected by the classic teaching (for eye 1, b = 0.04, p = 0.35; for eye 2, b = 0.07, p = 0.50). In 70 cases, the uniocular and binocular trials predicted a similar fraction of the variance in follow-up IOP(1C )(r(2 )= 0.56 and 0.57, respectively) and IOP(2C )(r(2 )= 0.39 and 0.38, respectively). CONCLUSION: 1) For uniocular trials, the IOP change in the untreated eye should not be subtracted from that in the treated eye. 2) Uniocular and binocular trials have similar predictive value when interpreted correctly. Either may be selected based on clinical circumstances.
format Text
id pubmed-2093925
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-20939252007-11-24 Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series Leffler, Christopher T Amini, Lina BMC Ophthalmol Research Article BACKGROUND: To predict the effectiveness of topical glaucoma medications based on initial uniocular and binocular treatment. To test a traditional hypothesis that effectiveness following a uniocular trial is associated with the change in IOP in the initially treated eye minus the change in the initially untreated eye. To determine whether uniocular or binocular treatment trials are superior. METHODS: Based on a review of medical records, we identified 168 instances in 154 patients with bilateral primary open angle glaucoma of initial uniocular use of a topical glaucoma medication with well-documented intraocular pressure (IOP) readings at baseline (IOP(A)), during the trial (IOP(B)), and at follow-up (IOP(C)). Abstracted data included demographic data, IOP, and medication use. Predictors of the IOP following the trial (IOP(C)) in each eye were identified by multivariable linear regression. In 70 cases, the predictive ability of initial uniocular and binocular treatment could be directly compared. RESULTS: In a multivariable analysis, the follow-up pressure in the initially treated eye (IOP(1C)) was directly correlated with treated eye IOP during initial uniocular use (IOP(1B), p < 0.001). In a multivariable analysis, the follow-up pressure in the initially untreated eye (IOP(2C)) was directly correlated with its baseline IOP(2A )(p < 0.001), and also tended to be associated with treated IOP(1B )(p = 0.07). The multivariable regression coefficient (b) for the IOP change in the initially untreated eye was generally not close to the value of -1 expected by the classic teaching (for eye 1, b = 0.04, p = 0.35; for eye 2, b = 0.07, p = 0.50). In 70 cases, the uniocular and binocular trials predicted a similar fraction of the variance in follow-up IOP(1C )(r(2 )= 0.56 and 0.57, respectively) and IOP(2C )(r(2 )= 0.39 and 0.38, respectively). CONCLUSION: 1) For uniocular trials, the IOP change in the untreated eye should not be subtracted from that in the treated eye. 2) Uniocular and binocular trials have similar predictive value when interpreted correctly. Either may be selected based on clinical circumstances. BioMed Central 2007-10-05 /pmc/articles/PMC2093925/ /pubmed/17916260 http://dx.doi.org/10.1186/1471-2415-7-17 Text en Copyright © 2007 Leffler and Amini; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Leffler, Christopher T
Amini, Lina
Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title_full Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title_fullStr Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title_full_unstemmed Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title_short Interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
title_sort interpretation of uniocular and binocular trials of glaucoma medications: an observational case series
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2093925/
https://www.ncbi.nlm.nih.gov/pubmed/17916260
http://dx.doi.org/10.1186/1471-2415-7-17
work_keys_str_mv AT lefflerchristophert interpretationofuniocularandbinoculartrialsofglaucomamedicationsanobservationalcaseseries
AT aminilina interpretationofuniocularandbinoculartrialsofglaucomamedicationsanobservationalcaseseries